VTRS (VTRS)

Market Cap
P/E Ratio
Beta
Dividend Yield
Piotroski 4/9Beneish M -3.26 Clean

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of VTRS reveal a company currently operating in a distressed phase, characterized by negative returns on invested capital at -8.4% and an ROE of -23.9%. A DuPont decomposition indicates that this poor equity return is driven primarily by severe margin compression rather than asset inefficiency or excessive leverage; specifically, net margins have contracted to -24.6%, which outweighs the impact of a 0.38x asset turnover and a 2.53x equity multiplier. While the Piotroski F-Score of 4/9 suggests moderate financial weakness without clear deterioration trends, the Beneish M-Score of -3.26 signals low probability of earnings manipulation. Despite these operational headwinds, gross margins remain robust at 35.1%, indicating that high fixed costs or pricing pressures on net income are likely distorting bottom-line performance rather than eroding core profitability power.

Valuation metrics present a significant divergence between current market pricing and intrinsic value estimates derived from discounted cash flow analysis. The DCF model assigns a fair value of $6, implying that the market is currently discounting future growth prospects heavily due to the persistent negative net margins and revenue contraction of -3.0% year-over-year. This wide gap suggests the stock may be trading below its calculated intrinsic worth based on projected recovery scenarios, yet it simultaneously prices in substantial risk regarding the sustainability of current operations given the lack of positive bottom-line expansion.

The data presents a classic value trap versus turnaround opportunity dichotomy where downside protection is theoretically offered by low valuation multiples relative to DCF fair value, but upside potential remains constrained until operational leverage improves and net margins normalize from their deeply negative levels. Investors must weigh whether the current price adequately compensates for the high probability of continued earnings volatility against the possibility that market overreaction has created a margin of safety not yet reflected in the consensus growth assumptions.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$9$5$2
3%$12$6$3
4%$17$8$4

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $6 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
-3.26
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

35.1%
Gross Margin
-24.6%
Net Margin
-8.4%
ROIC
-3.0%
Revenue Growth (YoY)
-454.2%
Earnings Growth (YoY)
1.9B
Free Cash Flow
30%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

-24.6%
Net Profit Margin
NI ÷ Revenue
×
0.38x
Asset Turnover
Revenue ÷ Assets
×
2.53x
Equity Multiplier
Assets ÷ Equity
=
-23.9%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.53x
Debt / Equity
1.38x
Current Ratio
-6.8x
Interest Coverage
-395.4M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.49
Act: $0.50
+1.6%
Q3
✓ Beat
Est: $0.56
Act: $0.62
+11.6%
Q2
✓ Beat
Est: $0.62
Act: $0.67
+8.5%
Q1
✓ Beat
Est: $0.53
Act: $0.57
+7.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

Forward P/E
PEG Ratio
Price/Book
Avg Volume
52W High
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$2.6B
Tracked Passive Exposure
8
ETFs Holding VTRS
0.04%
Avg Weight in ETFs
$5.9T
Total ETF AUM

When investors buy or sell ETFs like XPH or SPYD, the fund manager is mechanically forced to buy or sell VTRS shares regardless of VTRS's individual fundamentals. We estimate $2.6B of passive capital is structurally linked to VTRS through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in VTRS to visualize passive redemption contagion across ETFs and collateral stocks.

VTRS Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
VTRSEpicenterVTIETFVOOETFIVVETFLLYLow RiskJNJLow RiskMRKLow RiskABBVMed RiskUNHMed Risk
VTRS Price Drop (%)0

If VTRS (VTRS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ELI LILLY + CO (LLY) as the most exposed collateral stock, sharing 2 ETFs with VTRS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 28 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

VTRS Ownership Dynamics

Ticker
VTRS

Float lock-up computed from 28 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1213,757$16.92$232,768.44
2026-05-0841,581$17.39$723,093.59
2026-05-0749,775$15.95$793,911.25
2026-05-0548,206$15.20$732,731.2
2026-05-0464$15.04$962.56
2026-05-013,160$14.94$47,210.4
2026-04-271,657$14.59$24,175.63
2026-04-241,120$14.75$16,520
2026-04-21550$14.87$8,178.5
2026-04-204,075$14.68$59,821
2026-04-1733$14.01$462.33
2026-04-1649,436$13.86$685,182.96
2026-04-159$13.91$125.19
2026-04-14143$13.83$1,977.69
2026-04-10961$13.61$13,079.21
2026-04-0712$13.41$160.92
2026-04-0612$13.44$161.28
2026-03-251,484$13.36$19,826.24
2026-03-242,837$13.29$37,703.73
2026-03-198,229$13.74$113,066.46
2026-03-17167$13.51$2,256.17
2026-03-132,674$13.80$36,901.2
2026-03-103,308$14.22$47,039.76
2026-03-09483,731$14.16$6.8M
2026-03-03935$15.70$14,679.5
2026-03-021,191$14.93$17,781.63
2026-02-27920$15.25$14,030
2026-02-252,459$16.07$39,516.13
2026-02-2317$15.92$270.64
2026-02-20874$15.98$13,966.52

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare VTRS to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.